Intrahepatic Cholestasis of Pregnancy (ICP) is a complex liver disease which typically presents in the third trimester of pregnancy.
This course reviews the evidence for the best approach to risk-based management, and provides a plan for holistic preventative support of at-risk clients as well as the holistic treatment of clients with mild ICP in an out-of-hospital setting.
Approved by MEAC for 3 hours of continuing education (approval number M1920-33-1109DE through November 14, 2021).
This course is a fundraiser for the Midwives Association of Washington State (MAWS).
- 1.1 What is ICP?
- 1.2 Maternal and Fetal Etiology
- 1.3 Recent Meta-Analysis of Stillbirths Rate by Bile Acid Level
- 1.4 Risk Factors and S/S
- 1.5 Diagnostic Tests
- 2.1 Medical Management
- 2.2 Holistic Support and Treatment Options
- 2.3 A New Protocol: Holistic Prevention for ICP Recurrence
- 2.4 Expectant Management in the Community Birth Setting
- 2.5 Case Study
- 2.6 Continued Research
- 3.1 Points to Remember
- Printable PDF: Holistic Management Protocol for ICP
- 3.2 Q&A with Live Audience
- Article: Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses
- Article: RCOG Guideline No. 43 Obstretric Cholestasis
- Article: Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy
- Reading: Association of Severe Intrahepatic Cholestasis of Pregnancy With Adverse Pregnancy Outcomes: A Prospective Population-Based Case-Control Study
- Post-Test and CE Certificate